Tidal Investments’s Astria Therapeutics ATXS Stock Holding History

Tidal Investments’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-79,201	Closed	-$1.04M	–	2359
2025 Q4	$1.04M	Buy	+79,201	New	+$946K	﹤0.01%	1249
2024 Q2	–	Sell	-118,200	Closed	-$1.66M	–	1815
2024 Q1	$1.66M	Buy	+118,200	New	+$1.47M	0.03%	621

Tidal Investments's ATXS Position: Q1 2026 in Review

Tidal Investments sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 79,201 shares — an estimated $1.04M sold.

Tidal Investments first reported a position in ATXS in Q1 2024 and held it in 2 quarters. The position peaked at $1.66M in Q1 2024. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Tidal Investments reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Tidal Investments sold 79,201 Astria Therapeutics shares in Q1 2026, an estimated $1.04M.
Tidal Investments first reported a position in Astria Therapeutics in Q1 2024 and held it in 2 quarters.
Tidal Investments's Astria Therapeutics position peaked at $1.66M in Q1 2024.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.